HighTower Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $63M | Sell |
2,615,514
-32,629
| -1% | -$854K | 0.06% | 314 |
|
|
2026
Q1 | $74.4M | Buy |
2,648,143
+36,533
| +1% | +$973K | 0.08% | 250 |
|
|
2025
Q4 | $65M | Sell |
2,611,610
-133,130
| -5% | -$3.36M | 0.07% | 275 |
|
|
2025
Q3 | $69.9M | Sell |
2,744,740
-27,391
| -1% | -$676K | 0.08% | 251 |
|
|
2025
Q2 | $67.2M | Sell |
2,772,131
-127,710
| -4% | -$2.98M | 0.08% | 246 |
|
|
2025
Q1 | $73.5M | Buy |
2,899,841
+50,371
| +2% | +$1.32M | 0.1% | 214 |
|
|
2024
Q4 | $75.6M | Sell |
2,849,470
-370,020
| -11% | -$10M | 0.1% | 210 |
|
|
2024
Q3 | $93.1M | Buy |
3,219,490
+156,575
| +5% | +$4.57M | 0.13% | 169 |
|
|
2024
Q2 | $85.7M | Sell |
3,062,915
-2,207
| -0.1% | -$60.8K | 0.13% | 167 |
|
|
2024
Q1 | $85.1M | Buy |
3,065,122
+229,290
| +8% | +$6.36M | 0.14% | 169 |
|
|
2023
Q4 | $81.7M | Sell |
2,835,832
-430,898
| -13% | -$13M | 0.14% | 160 |
|
|
2023
Q3 | $108M | Sell |
3,266,730
-19,166
| -0.6% | -$678K | 0.2% | 110 |
|
|
2023
Q2 | $121M | Sell |
3,285,896
-20,651
| -0.6% | -$804K | 0.24% | 87 |
|
|
2023
Q1 | $135M | Sell |
3,306,547
-304,170
| -8% | -$13.1M | 0.29% | 73 |
|
|
2022
Q4 | $185M | Buy |
3,610,717
+246,101
| +7% | +$11.8M | 0.42% | 41 |
|
|
2022
Q3 | $147M | Sell |
3,364,616
-178,029
| -5% | -$8.65M | 0.39% | 45 |
|
|
2022
Q2 | $186M | Sell |
3,542,645
-6,679
| -0.2% | -$340K | 0.48% | 32 |
|
|
2022
Q1 | $184M | Sell |
3,549,324
-442,238
| -11% | -$22.9M | 0.41% | 44 |
|
|
2021
Q4 | $236M | Buy |
3,991,562
+330,771
| +9% | +$16.4M | 0.52% | 32 |
|
|
2021
Q3 | $157M | Buy |
3,660,791
+319,130
| +10% | +$14.1M | 0.42% | 40 |
|
|
2021
Q2 | $131M | Buy |
3,341,661
+193,291
| +6% | +$7.52M | 0.38% | 50 |
|
|
2021
Q1 | $114M | Buy |
3,148,370
+150,715
| +5% | +$5.35M | 0.36% | 56 |
|
|
2020
Q4 | $110M | Buy |
2,997,655
+286,626
| +11% | +$10.5M | 0.46% | 39 |
|
|
2020
Q3 | $94.4M | Buy |
2,711,029
+440,420
| +19% | +$15.4M | 0.46% | 42 |
|
|
2020
Q2 | $70.4M | Buy |
2,270,609
+161,441
| +8% | +$5.48M | 0.38% | 51 |
|
|
2020
Q1 | $65.3M | Buy |
2,109,168
+229,617
| +12% | +$7.82M | 0.42% | 46 |
|
|
2019
Q4 | $70M | Sell |
1,879,551
-15,101
| -0.8% | -$538K | 0.41% | 51 |
|
|
2019
Q3 | $64.6M | Buy |
1,894,652
+111,346
| +6% | +$4.05M | 0.35% | 56 |
|
|
2019
Q2 | $73.2M | Sell |
1,783,306
-177,373
| -9% | -$7.04M | 0.44% | 42 |
|
|
2019
Q1 | $78.9M | Buy |
1,960,679
+27,620
| +1% | +$1.11M | 0.53% | 31 |
|
|
2018
Q4 | $80M | Buy |
1,933,059
+75,621
| +4% | +$3.14M | 0.61% | 27 |
|
|
2018
Q3 | $77.6M | Sell |
1,857,438
-50,691
| -3% | -$1.95M | 0.56% | 29 |
|
|
2018
Q2 | $65.7M | Sell |
1,908,129
-27,992
| -1% | -$957K | 0.51% | 33 |
|
|
2018
Q1 | $65.2M | Sell |
1,936,121
-14,731
| -0.8% | -$506K | 0.55% | 28 |
|
|
2017
Q4 | $67M | Buy |
1,950,852
+33,281
| +2% | +$1.13M | 0.55% | 30 |
|
|
2017
Q3 | $65M | Sell |
1,917,571
-476,786
| -20% | -$15.3M | 0.55% | 28 |
|
|
2017
Q2 | $76.3M | Sell |
2,394,357
-160,103
| -6% | -$5.05M | 0.68% | 15 |
|
|
2017
Q1 | $82.8M | Buy |
2,554,460
+53,938
| +2% | +$1.7M | 0.79% | 16 |
|
|
2016
Q4 | $76.9M | Buy |
2,500,522
+289,175
| +13% | +$8.83M | 0.84% | 16 |
|
|
2016
Q3 | $71M | Buy |
2,211,347
+93,393
| +4% | +$3.12M | 0.82% | 15 |
|
|
2016
Q2 | $70.9M | Sell |
2,117,954
-84,386
| -4% | -$2.69M | 0.9% | 15 |
|
|
2016
Q1 | $62M | Buy |
2,202,340
+40,331
| +2% | +$1.15M | 0.2% | 25 |
|
|
2015
Q4 | $66.2M | Buy |
2,162,009
+32,313
| +2% | +$1.02M | 0.79% | 17 |
|
|
2015
Q3 | $63.4M | Buy |
2,129,696
+240,242
| +13% | +$7.7M | 0.84% | 17 |
|
|
2015
Q2 | $60.2M | Buy |
1,889,454
+335,627
| +22% | +$10.9M | 0.96% | 15 |
|
|
2015
Q1 | $51.3M | Sell |
1,553,827
-148,194
| -9% | -$4.71M | 0.76% | 18 |
|
|
2014
Q4 | $50.3M | Buy |
1,702,021
+21,256
| +1% | +$609K | 0.77% | 14 |
|
|
2014
Q3 | $47.2M | Buy |
1,680,765
+172,564
| +11% | +$4.84M | 0.8% | 15 |
|
|
2014
Q2 | $42.5M | Buy |
1,508,201
+121,365
| +9% | +$3.46M | 0.74% | 17 |
|
|
2014
Q1 | $42.3M | Buy |
1,386,836
+291,164
| +27% | +$8.68M | 0.82% | 15 |
|
|
2013
Q4 | $31.8M | Buy |
1,095,672
+30,524
| +3% | +$888K | 0.65% | 23 |
|
|
2013
Q3 | $29M | Buy |
1,065,148
+3,707
| +0.3% | +$101K | 0.73% | 22 |
|
|
2013
Q2 | $28.2M | Buy |
+1,061,441
| New | +$29.3M | 0.77% | 20 |
|
Other funds holding PFE
HighTower Advisors's PFE Position: Q2 2026 in Review
HighTower Advisors reduced its Pfizer (PFE) stake by 1.2% in Q2 2026, selling an estimated $854K and leaving 2,615,514 shares worth $63M. The position accounts for 0.06% of the portfolio, ranked #314.
HighTower Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $236M in Q4 2021. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- HighTower Advisors held 2,615,514 shares of Pfizer worth $63M as of Q2 2026.
- HighTower Advisors sold 32,629 Pfizer shares in Q2 2026, an estimated $854K.
- Pfizer made up 0.06% of HighTower Advisors's portfolio in Q2 2026, its #314 holding.
- HighTower Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- HighTower Advisors's Pfizer position peaked at $236M in Q4 2021.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.